Two recent large studies demonstrated that CHEK2 is the second most frequently altered breast cancer predisposition gene among patients of European descent, surpassed by BRCA2 and followed by BRCA1 in frequency of germline pathogenic variants (7, 8). This evidence concerns the gene CHEK2 and breast cancer.